RecruitingNot ApplicableNCT06234501

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism

Sponsor

University of Reading

Enrollment

40 participants

Start Date

Nov 8, 2024

Study Type

INTERVENTIONAL

Conditions

Autism

Summary

This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria2

Between the ages of 18 to 60
With a diagnosis of autism

Exclusion Criteria3

Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
Have a medical history of peripheral neuropathy
lactose intolerance (placebo tablet is lactose based)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPyridoxal 5'-Phosphate (100 mg)

100 mg Pyridoxal 5'-Phosphate tablet once daily with food

OTHERPlacebo

Placebo tablet once daily

Locations(1)

University of Reading

Reading, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06234501

Related Trials

Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health

NCT070423471 location